Cervical Squamous Cell Carcinoma — Trials

Cervical Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 44%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 16.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07649395	A Prospective Study of the Early Treatment of Recombinant Human Thrombopoietin for Chemoradiation Induced Thrombocytopenia in Cervical Squamous Cell Carcinoma Patient	completed	N/A	75	Mei FengOTHER	1	Jun 16, 2026	clinicaltrials

Data updated 23 days agoSource updated Jun 16, 2026source: clinicaltrials